Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending Topics
Clinical Development
Biologics
Fierce 50
Special Report
Awards Gala
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Trending T
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending Topics
Clinical Development
Biologics
Fierce 50
Special Report
Awards Gala
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Deals
Biotech
Novartis pays PTC $1B upfront for midphase Huntington's program
The biotech has built its case for the oral candidate around evidence it reduces levels of the protein in the central nervous system and periphery.
Nick Paul Taylor
Dec 2, 2024 7:53am
Idorsia teases Tryvio licensing deal while planning 270 layoffs
Nov 27, 2024 4:15am
Acadia inks $582M biobucks pact for Danish biotech's neuro asset
Nov 26, 2024 5:00pm
Sarepta, Arrowhead ink $1B-plus deal for seven programs
Nov 26, 2024 11:18am
Roche inks $1.5B Poseida buyout to land off-the-shelf CAR-Ts
Nov 26, 2024 6:00am
Gilead buys HIV vaccine from biotech following clinical collab
Nov 25, 2024 10:30am